SCHEMBL4903020

SCHEMBL4903020

Clc1ccc(Nc2cccc(-c3ncccn3)n2)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.51
KDR P35968 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
KDM4E B2RXH2 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
KMT2A Q03164 3/20 0.42
HTT P42858 2/20 0.42
MEN1 O00255 2/20 0.42
MAPT P10636 1/20 0.42
XBP1 P17861 1/20 0.42
NFKB1 P19838 1/20 0.42
AHR P35869 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
PDE10A Q9Y233 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4891120 0.85 SLC2A1 (0.62) SLC2A1KDRSMN1; SMN2KDM4ENPC1
SCHEMBL4898748 0.84 SLC2A1 (0.50) SLC2A1KDRSMN1; SMN2KDM4ENPC1
SCHEMBL2823612 0.81 SLC2A1 (0.57) SLC2A1KDRSMN1; SMN2KDM4ENPC1
SCHEMBL4901584 0.81 SLC2A1 (0.48) SLC2A1KDRSMN1; SMN2KDM4ENPC1
SCHEMBL4892301 0.81 SLC2A1 (0.44) SLC2A1KDRSMN1; SMN2KDM4ENPC1
Hydrochloric Acid SCHEMBL4896691 0.80 SLC2A1 (0.47) SLC2A1KDRSMN1; SMN2KDM4ENPC1
SCHEMBL4900760 0.79 KARS1 (0.40) KDRSMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL4901358 0.79 SLC2A1 (0.49) SLC2A1KDRSMN1; SMN2KDM4ENPC1
SCHEMBL2226110 0.77 SLC2A1 (0.44) SLC2A1KDRSMN1; SMN2KDM4ENPC1
SCHEMBL4901278 0.76 KDR (0.46) SLC2A1KDRSMN1; SMN2KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators ICAGEN, INC. (US) 2008-05-08 US disclosed
EP-1737852-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS Icagen, Inc. (US) 2007-01-03 EP disclosed
WO-2005100349-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN, INC. (US) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators KCNJ2, KCNH2, KCNQ1 SLC2A1 2369/4885KDR 3367/4885SMN1; SMN2 3670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.